Ravelcare Limited (BOM:544629)
India · Delayed Price · Currency is INR 191.50
-11.30 (-5.57%)
At close: Feb 12, 2026
Ravelcare Revenue
In the fiscal year ending March 31, 2025, Ravelcare had annual revenue of 249.79M INR with 13.09% growth. Ravelcare had revenue of 71.99M in the quarter ending September 30, 2025.
Revenue
249.79M
Revenue Growth
+13.09%
P/S Ratio
5.15
Revenue / Employee
9.99M
Employees
20
Market Cap
1.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 249.79M | 28.91M | 13.09% |
| Mar 31, 2024 | 220.88M | 185.94M | 532.23% |
| Mar 31, 2023 | 34.94M | 27.05M | 343.01% |
| Mar 31, 2022 | 7.89M | 7.20M | 1,046.28% |
| Mar 31, 2021 | 687.97K | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Emami | 38.17B |
| Bajaj Consumer Care | 10.89B |
| Anondita Medicare | 996.83M |
| Aakaar Medical Technologies | 592.04M |
| MFL India | 576.82M |
| Paramount Cosmetics (India) | 245.82M |
| Novateor Research Laboratories | 44.54M |
| Raghunath International | 13.64M |